Preclinical Assets

topic on 1 show · 1 statements across 1 episodes

the a16z Podcast

1 statements about Preclinical Assets, every show

a16z Insight
Lowe: Preclinical bio assets lack significant value until reaching clinical trials
“That is because in the bio space value is created in these huge technical milestones in the very beginning where a lot of these services are used. These are preclinical assets in which there's really not too much value until you bring a drug candidate into the…”
Jeffrey Lowe Apr 30, 2018 ▶ 4:57 Shifting Risk Mindsets, from Tech to Bio

← every entity, every show

Made with StarZero

Turn any episode into a week of clips.

This entire site, thousands of episodes across every show transcribed, diarized, checked and made playable, runs on the StarZero media pipeline. Drop in your own episode and the podcast clipper finds the moments worth sharing, cuts them, captions them, and reframes them for every feed.